**Core Concept:** Osteoblasts are bone-forming cells that play a crucial role in bone remodeling and maintaining bone mass. Drugs that stimulate osteoblasts can increase bone density and reduce the risk of osteoporosis.

**Why the Correct Answer is Right:** Calcitonin is a hormone derived from the thyroid gland that plays a crucial role in calcium homeostasis. By inhibiting osteoclasts (bone-resorbing cells), calcitonin reduces the resorption of bone matrix and consequently stimulates osteoblasts. This leads to increased bone density and reduced risk of osteoporosis.

**Why Each Wrong Option is Incorrect:**

A. Parathyroid hormone (PTH) is another hormone that regulates calcium homeostasis, but it primarily stimulates osteoclasts, leading to increased bone resorption and decreased bone density.

B. Estrogens are sex hormones that, besides their effects on reproductive organs, also influence bone remodeling. While they can increase bone density by stimulating osteoblasts, they do so to a lesser extent than calcitonin.

C. Thiazide diuretics reduce calcium excretion in the urine, but their effect on osteoblasts is minimal compared to calcitonin.

D. Alendronate is a bisphosphonate drug, which inhibits osteoclast activity, but it does not have the same direct stimulatory effect on osteoblasts as calcitonin.

**Clinical Pearl:** Calcitonin is a potent osteoclast inhibitor and osteoblast stimulator, making it a useful therapeutic option for patients with osteoporosis. It can be administered via subcutaneous injections or inhalation formulations.

**Correct Answer:** Calcitonin (C)

---

Calcitonin is a hormone produced by the posterior pituitary gland and thyroid gland, primarily regulating calcium homeostasis. Unlike other options, calcitonin directly stimulates osteoblasts (bone-forming cells) and inhibits osteoclasts (bone-resorbing cells), thereby promoting bone formation and reducing bone resorption. This action contributes to increased bone density and reduced risk of osteoporosis.